Global Drug of Abuse (DOA) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Drug of Abuse (DOA) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The drug of abuse test is an immunoassay based on the principle of competitive binding.
Global Drug of Abuse (DOA) Testing market is projected to reach US$ 9703.7 million in 2033, increasing from US$ 6321 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2033. Demand from Hospitals and Laboratories are the major drivers for the industry.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug of Abuse (DOA) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug of Abuse (DOA) Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug of Abuse (DOA) Testing introduction, etc. Drug of Abuse (DOA) Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug of Abuse (DOA) Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Global Drug of Abuse (DOA) Testing market is projected to reach US$ 9703.7 million in 2033, increasing from US$ 6321 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2033. Demand from Hospitals and Laboratories are the major drivers for the industry.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug of Abuse (DOA) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug of Abuse (DOA) Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug of Abuse (DOA) Testing introduction, etc. Drug of Abuse (DOA) Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug of Abuse (DOA) Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices